GlassScriptPhysician profile
Matthew A Pierce
NPI 1508209305
$5,352.28
in general payments reported to CMS, 2019-2025
27 companies · $675 in 2025
The $675 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $563 · 2021: $56.74 · 2022: $456 · 2023: $2,649 · 2024: $667 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,312 · Travel and Lodging: $1,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,312.05 |
| Travel and Lodging | $1,679.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,494.88 | 2021-2025 | Interstim |
| Procept Biorobotics Corporation | $852.44 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| Neotract INC. | $434.81 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $374.82 | 2022-2025 | Provenge |
| Sumitomo Pharma America, INC. | $272.92 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $264.08 | 2019-2024 | Lynx System, Advantage System |
| Myriad Genetic Laboratories, INC. | $250.81 | 2023 | Prolaris |
| Teleflex LLC | $169.60 | 2022-2024 | Urolift |
| Coloplast Corp | $156.65 | 2020-2025 | Saffron |
| Astellas Pharma US INC | $110.88 | 2020 | |
| Pfizer INC. | $102.15 | 2023-2025 | |
| Smith+Nephew, INC. | $95.53 | 2025 | Stravix |
| Urogen Pharma, INC. | $92.40 | 2022 | |
| Abbvie INC. | $86.41 | 2025 | |
| Olympus America INC. | $85.22 | 2020-2025 | Itind System, Uropass |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $78.69 | 2022 | |
| Endo USA, INC. | $65.79 | 2025 | Xiaflex, Aveed |
| Endo Pharmaceuticals INC. | $64.28 | 2019-2024 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $54.96 | 2023-2024 | Keytruda, Lynparza |
| Abc Home Medical Supply, INC. | $53.77 | 2025 | |
| Convatec INC. | $40.03 | 2023 | |
| Photocure INC | $34.93 | 2022-2023 | Cysview |
| Tolmar, INC. | $26.34 | 2023 | |
| Calyxo, INC. | $26.33 | 2024 | Cvac Aspiration System |
| Blue Earth Diagnostics | $24.35 | 2024 | |
| Profound Medical Corp. | $19.83 | 2025 | Tulsa-Pro |
| Urovant Sciences INC | $19.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.